Incyte (INCY) Halts Planned Phase 3 Ovarian Cancer Study, Citing Portfolio Prioritization
Company Says Decision on INCB123667 Was Not Driven by Safety or Efficacy Findings and Does Not Affect Financial Guidance Related Stocks: INCY ,
Company Says Decision on INCB123667 Was Not Driven by Safety or Efficacy Findings and Does Not Affect Financial Guidance Related Stocks: INCY ,